Equibles does not estimate personal net worth.
The proxy statement of Altimmune, Inc. reports total compensation of $670,183 for Scott Harris in fiscal 2020, including a base salary of $377,092. Disclosed compensation is on record for 3 fiscal years. Scott Harris has spoken on 1 earnings call across 1 company, most recently for Altimmune, Inc. on February 27, 2025. The companies whose calls Scott Harris spoke on are classified in the Healthcare sector.
“As Vipin mentioned, after 25 years in drug development, including the past six years at Altimmune, I've decided to plan for my departure in early 2026. I want to emphasize that I will remain with the company through all important milestones over the next 12 months, and that I'm not going anywhere anytime soon.”
Source not stated
Start not stated–2026-02-28
ALT
Biotechnology · Healthcare
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Altimmune, Inc. (ALT) | Chief Medical Officer | $377,092 | $670,183 |
| 2019 | Altimmune, Inc. (ALT) | Chief Medical Officer | $115,032 | $382,908 |
| 2018 | Altimmune, Inc. (ALT) | Chief Medical Officer | — | — |
